Package 10122-901-12

{"route": ["ORAL"], "spl_id": "d49e40c7-0635-4220-8b0a-c5068116ee17", "openfda": {"nui": ["N0000175956", "N0000175955", "N0000008683"], "unii": ["V1L22WVE2S"], "rxcui": ["199904", "211777"], "spl_set_id": ["aee65202-fddb-497f-9f11-17cc727cb157"], "pharm_class_pe": ["Decreased Leukotriene Production [PE]"], "pharm_class_epc": ["5-Lipoxygenase Inhibitor [EPC]"], "pharm_class_moa": ["5-Lipoxygenase Inhibitors [MoA]"], "manufacturer_name": ["Chiesi USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (10122-901-12)", "package_ndc": "10122-901-12", "marketing_end_date": "20271130", "marketing_start_date": "19961206"}], "brand_name": "ZYFLO", "product_id": "10122-901_d49e40c7-0635-4220-8b0a-c5068116ee17", "dosage_form": "TABLET", "pharm_class": ["5-Lipoxygenase Inhibitor [EPC]", "5-Lipoxygenase Inhibitors [MoA]", "Decreased Leukotriene Production [PE]"], "product_ndc": "10122-901", "generic_name": "zileuton", "labeler_name": "Chiesi USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZYFLO", "active_ingredients": [{"name": "ZILEUTON", "strength": "600 mg/1"}], "application_number": "NDA020471", "marketing_category": "NDA", "marketing_end_date": "20271130", "marketing_start_date": "19961206"}